 Sarah Nelson-Taylor
Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-ret | 1 | 2017 | 41 | 0.500 |
Why?
| | Pyridazines | 1 | 2017 | 57 | 0.500 |
Why?
| | GTP Phosphohydrolases | 1 | 2017 | 93 | 0.490 |
Why?
| | Gene Rearrangement | 1 | 2017 | 156 | 0.470 |
Why?
| | Imidazoles | 1 | 2017 | 247 | 0.460 |
Why?
| | MAP Kinase Signaling System | 1 | 2017 | 308 | 0.440 |
Why?
| | Sarcoma, Ewing | 2 | 2025 | 103 | 0.390 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 883 | 0.340 |
Why?
| | Membrane Proteins | 1 | 2017 | 1166 | 0.320 |
Why?
| | Oncogenes | 2 | 2023 | 118 | 0.310 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 1191 | 0.270 |
Why?
| | Bone Neoplasms | 2 | 2025 | 265 | 0.230 |
Why?
| | Genetic Heterogeneity | 1 | 2025 | 66 | 0.220 |
Why?
| | Clonal Evolution | 1 | 2025 | 47 | 0.210 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2667 | 0.200 |
Why?
| | Cadherins | 1 | 2024 | 200 | 0.190 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 212 | 0.180 |
Why?
| | beta Catenin | 1 | 2024 | 254 | 0.180 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 361 | 0.170 |
Why?
| | Renal Dialysis | 1 | 2026 | 466 | 0.170 |
Why?
| | Kidney Failure, Chronic | 1 | 2026 | 599 | 0.150 |
Why?
| | Biomarkers, Tumor | 1 | 2025 | 1329 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2026 | 874 | 0.130 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2017 | 231 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2017 | 383 | 0.110 |
Why?
| | Cell Line, Tumor | 2 | 2024 | 3551 | 0.100 |
Why?
| | ErbB Receptors | 1 | 2017 | 635 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 1 | 2017 | 625 | 0.100 |
Why?
| | Cell Proliferation | 1 | 2017 | 2514 | 0.070 |
Why?
| | Mutation | 1 | 2017 | 4090 | 0.060 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2025 | 81 | 0.050 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 1 | 2024 | 30 | 0.050 |
Why?
| | RNA-Binding Protein EWS | 1 | 2024 | 31 | 0.050 |
Why?
| | Peritoneal Dialysis | 1 | 2026 | 100 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 442 | 0.050 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2024 | 212 | 0.050 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2026 | 390 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 735 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2025 | 1450 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1777 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2023 | 981 | 0.030 |
Why?
| | Prognosis | 1 | 2025 | 4329 | 0.030 |
Why?
| | Mice | 2 | 2024 | 18355 | 0.030 |
Why?
| | Humans | 4 | 2026 | 145763 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2026 | 6464 | 0.030 |
Why?
| | Infant | 1 | 2026 | 10090 | 0.020 |
Why?
| | Animals | 2 | 2024 | 38097 | 0.020 |
Why?
| | United States | 1 | 2026 | 16123 | 0.020 |
Why?
| | Male | 2 | 2026 | 73003 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2026 | 17325 | 0.020 |
Why?
| | Female | 2 | 2026 | 79035 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 22573 | 0.010 |
Why?
| | Child | 1 | 2025 | 22739 | 0.010 |
Why?
|
|
Nelson-Taylor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|